Michael Crider
Pituitary-Directed Drug Therapy for the Treatment of Cushing’s Disease
Cushing’s disease (CD) is usually the result of an adrenocorticotropic hormone (ACTH)-secreting pituitary adenoma. The result is overstimulation of the adrenal glands leading to chronic hypercortisolism. Individuals with CD have increased risks of hypertension, obesity, hyperglycemia, infections, and vascular damage. Transsphenoidal surgery of the pituitary adenoma is the preferred option in the treatment of CD. The success rates are 65- 90% for microadenomas; however, as many as 40% of patients will experience recurrence within 10 years.
English 
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi